Bauerfeind Ingo, Himsl Isabelle, Kühn Thorsten, Untch Michael, Hepp Hermann
Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe-Grosshadern, Ludwig-Maximilians-Universität München, Deutschland.
Gynakol Geburtshilfliche Rundsch. 2004 Apr;44(2):84-91. doi: 10.1159/000076861.
Axillary lymph node excision of level I and II with at least 10 lymph nodes is the operative gold standard for invasive breast cancer. Axillary lymph node excision is a diagnostic procedure for histopathologic tumor classification, for assessment of prognosis, local tumor control and adjuvant therapy decision. The sentinel node biopsy is a minimal-invasive procedure to determine the axillary lymph node status by excision of one or more sentinel nodes. This procedure is being increasingly implemented in breast cancer surgery. The classical axillary lymph node excision can be replaced by sentinel node biopsy if sentinel nodes are free of invasion in the intraoperative as well as in the final histopathological report. Sentinel node biopsy can become an operative routine procedure only in a quality-controlled environment.
对I级和II级腋窝淋巴结进行切除，且切除的淋巴结至少有10个，是浸润性乳腺癌的手术金标准。腋窝淋巴结切除是一种诊断性手术，用于组织病理学肿瘤分类、评估预后、局部肿瘤控制以及辅助治疗决策。前哨淋巴结活检是一种微创手术，通过切除一个或多个前哨淋巴结来确定腋窝淋巴结状态。该手术在乳腺癌手术中应用越来越广泛。如果术中及最终组织病理学报告显示前哨淋巴结无转移，经典的腋窝淋巴结切除可被前哨淋巴结活检取代。只有在质量可控的环境中，前哨淋巴结活检才能成为一种常规手术。
